Amedisys (AMED) Tops Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts AMED Hot Sheet
Price: $91.16 +0.12%
EPS Growth %: +2.0%
Financial Fact:
Net service revenue: 361.6M
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: +2.0%
Financial Fact:
Net service revenue: 361.6M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q3 EPS of $0.26, $0.11 better than the analyst estimate of $0.15. Revenue for the quarter came in at $300.3 million versus the consensus estimate of $299.26 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Data I/o Corp (DAIO) Misses Q2 EPS by 7c
- Byline Bancorp (BY) Tops Q1 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
